# Dexmedetomidine and Nalbuphine as Analgesic Adjuvants to Bupivacaine in Superficial Cervical Block.

> **NCT06490614** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Kasr El Aini Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Anterior Cervical Discectomy and Fusion (ACDF)

## Interventions

- **DRUG:** Dexmedetomidine in superficial cervical plexus block
- **DRUG:** Nalbuphine in superficial cervical plexus block

## Key facts

- **NCT ID:** NCT06490614
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2024-10
- **Final completion:** 2024-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06490614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06490614, "Dexmedetomidine and Nalbuphine as Analgesic Adjuvants to Bupivacaine in Superficial Cervical Block.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06490614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*